Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
Hepatitis C virus (HCV) infection or HCV-related liver diseases are now shown to cause more than 350,000 deaths every year. Adaptability of HCV genome to vary its composition and the existence of multiple strains makes it more difficult to combat the emergence of drug-resistant HCV infections. Among...
Saved in:
Main Authors: | Harikishore, Amaravadhi, Li, Enlin, Lee, Jia Jun, Cho, Nam-Joon, Yoon, Ho Sup |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/97886 http://hdl.handle.net/10220/38515 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Revisiting De Novo drug design : receptor based pharmacophore screening
by: Yoon, Ho Sup, et al.
Published: (2015) -
The NS5A domain II of HCV : conservation of intrinsic disorder in several genotypes
by: Hanoulle, Xavier, et al.
Published: (2012) -
Cell Penetrable Humanized-VH/V<inf>H</inf>H That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV
by: Kanyarat Thueng-in, et al.
Published: (2018) -
Inhibition of HCV replication by humanized-single domain transbodies to NS4B
by: Kittirat Glab-ampai, et al.
Published: (2018) -
Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics
by: Bodee Nutho, et al.
Published: (2018)